HSA
BEAT

Hussman Strategic Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Hussman Strategic Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15,000
Closed -$939K – 264
2019
Q1 		$939K Sell
15,000
-10,000
-40% -$687K 0.23% 157
2018
Q4 		$1.49M Buy
+25,000
New +$1.5M 0.36% 120
2018
Q3 		– Sell
-50,000
Closed -$2.25M – 257
2018
Q2 		$2.25M Sell
50,000
-25,000
-33% -$997K 0.61% 70
2018
Q1 		$2.33M Buy
+75,000
New +$2.47M 0.65% 75

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hussman Strategic Advisors's BEAT Position: Q2 2019 in Review

Hussman Strategic Advisors sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 15,000 shares — an estimated $939K sold.

Hussman Strategic Advisors first reported a position in BEAT in Q1 2018 and held it in 4 quarters. The position peaked at $2.33M in Q1 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

  • Hussman Strategic Advisors reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
  • Hussman Strategic Advisors sold 15,000 BioTelemetry, Inc. shares in Q2 2019, an estimated $939K.
  • Hussman Strategic Advisors first reported a position in BioTelemetry, Inc. in Q1 2018 and held it in 4 quarters.
  • Hussman Strategic Advisors's BioTelemetry, Inc. position peaked at $2.33M in Q1 2018.
  • 251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Hussman Strategic Advisors's 13F filing for Q2 2019, filed 31 Jul 2019.